Incorporating Patient Voices and Priorities in Genomic Testing, Research and Treatment Development with Nan Doyle, MS, MS, LCGC

• This presentation will identify touchpoints in the diagnosis and drug-development continuum where early/systematic insight into patient perspectives can help accelerate availability of new treatments, differentiate an asset, and add reputational value. Industry, payers, regulators, and investors increasingly seek patient perspective to de-risk their decisions; and patients themselves are keen to partner. 

  Level of instruction: Basic

  

  Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

  

  Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.

Nan Doyle, MS, MS, LCGC | Presenter

Principal at Trillium Advisors

Nan Doyle is a patient engagement catalyst who helps emerging companies embed patient perspective into every nook and cranny of rare-disease drug discovery and development, especially when new gene-modification modalities are involved. She has a passion to strengthen access to diagnosis and treatment for people living with rare genetic conditions.

Most recently, Nan established and built the Rare Disease Patient Engagement function for Takeda Pharmaceuticals. She has held innovative, successful roles in multiple areas of drug development, with bright lights in rare disease medicine including Alnylam, Genzyme, Massachusetts General Hospital, the Boston Museum of Science, Parexel, and Harvard Medical School.

Nan is also a board-certified genetic counselor, where she developed front-line understanding of patient and care partner practical, emotional, financial and policy needs.

Libby Couchon, MS, LCGC | Moderator

Genomic Science Liaison II at Ambry Genetics

Libby Couchon, MS, LCGC, is a Genomic Science Liaison at Ambry Genetics. She is certified by the American Board of Genetic Counseling and is a licensed Genetic Counselor in the state of Massachusetts. She received her Master’s in Genetic Counseling from Virginia Commonwealth University in 2001. After training at VCU, she spent 2 years as a clinical counselor in the General Genetics clinic at Nationwide Children’s Hospital in Columbus, OH before transitioning to industry. Libby has over 20 years of experience as an industry counselor focusing on the development of clinically relevant diagnostic testing for rare diseases and leading clinical education initiatives for patients and providers.